NFE2L2 and lung cancer: This likely reflects the fact that, in some pathologies, such as lung cancer, inhibition of the Nrf2 pathway could be beneficial, as it could reduce the aggressiveness of the tumor and/or increase its responsiveness to standard chemotherapy [53,54,55].